Market Capitalization (Millions $) |
- |
Shares
Outstanding (Millions) |
22 |
Employees |
- |
Revenues (TTM) (Millions $) |
- |
Net Income (TTM) (Millions $) |
-63 |
Cash Flow (TTM) (Millions $) |
0 |
Capital Exp. (TTM) (Millions $) |
1 |
Checkmate Pharmaceuticals Inc
Checkmate Pharmaceuticals Inc is a biopharmaceutical company that specializes in developing immunotherapies to treat cancer. The company focuses on the development of a class of molecules called Toll-like Receptor 9 agonists, which have shown promise in stimulating the immune system to target and destroy cancer cells. Checkmate Pharmaceuticals aims to provide a new, effective treatment option for cancer patients through innovative and targeted therapies.
Company Address: 245 Main Street Cambridge 2142 MA
Company Phone Number: 682-3625 Stock Exchange / Ticker: NASDAQ CMPI
|